Chronic lymphocytic leukemia
ICD-10 C91.1 · ICD-11 2A82.0

Management of Asymptomatic Early-Stage CLL When iwCLL Treatment Criteria Are Not Met

A newly diagnosed patient with chronic lymphocytic leukaemia does not always require immediate CLL-directed therapy. This protocol applies specifically when disease is asymptomatic and early-stage, and the internationally accepted iwCLL criteria for initiating treatment have not been reached.

Clinical Scenario

The patient has asymptomatic early-stage chronic lymphocytic leukaemia. The iwCLL criteria for starting CLL-directed treatment are not met. Evidence — including data from the CLL12 trial — confirms that beginning active CLL therapy in this setting does not improve outcomes, including for patients considered at high risk of early progression.

Approach Overview

No CLL-directed therapy is indicated at this stage. The recommended approach centres on structured active monitoring, alongside supportive measures from the point of diagnosis. Prehabilitation — where locally available — is part of initial management for newly diagnosed patients.

The full protocol details — including the monitoring framework, prehabilitation guidance, and the clinical thresholds that would prompt reassessment — are available via the structured regimen below.

Instant Access to Structured Evidence-Based Regimens

References

View source ↗